APA (7th ed.) Citation

M, R. K., AM, P., PB, P., G, S., D, G., & HM, M. C. (2025). Author Response: Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology, 104(3), e209824. https://doi.org/10.1212/WNL.0000000000209824

Chicago Style (17th ed.) Citation

M, Robert Keezer, Pack AM, Pennell PB, Saade G, Gloss D, and Munger Clary HM. "Author Response: Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM." Neurology 104, no. 3 (2025): e209824. https://doi.org/10.1212/WNL.0000000000209824.

MLA (9th ed.) Citation

M, Robert Keezer, et al. "Author Response: Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM." Neurology, vol. 104, no. 3, 2025, p. e209824, https://doi.org/10.1212/WNL.0000000000209824.